openPR Logo
Press release

Carcinoid Tumor Market To Reach Around 10.0% CAGR till 2023 by Top Players as Novartis AG, Amgen, Boehringer Ingelheim GmbH, AVEO Pharmaceuticals, Chiasma, Aegis Therapeutics, etc

11-15-2018 08:58 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Carcinoid Tumor Market

Carcinoid Tumor Market

Carcinoid tumor is a type of the neuroendocrine tumor. The most common site of carcinoid tumors is the GI (gastrointestinal) tract and the lungs. However, it can also be developed in pancreas, testicles, and ovaries. The increasing prevalence of the carcinoid tumor is expected to drive the market growth. According to the American Society of Clinical Oncology (ASCO) in 2016, approximately 8,000 adults in the US were diagnosed with a carcinoid tumor in their GI tract. Moreover, it was also estimated that each year approximately 4,000 adults in the US are diagnosed with a carcinoid tumor in their lung. Moreover, growing geriatric population along with rising healthcare expenditure is likely to boost the market growth during the forecast period. However, lack of awareness, high treatment cost and related side effects may hamper the market growth during the forecast period.

The Global Carcinoid Tumor Market is expected to grow at an approximate of CAGR of 10.5% during forecast period.

To Get Sample Report visit https://www.marketresearchfuture.com/sample_request/4813

Key Players for Global Carcinoid Tumor Market

Market Research Future (MRFR) recognizes the following companies as the key players in Carcinoid Tumor Market: There are plenty of large and small market players which operate in this market all over the globe.

Some of the key players in the global carcinoid tumor market are Novartis AG (Europe), Amgen Inc. (U.S.), Boehringer Ingelheim GmbH (Europe), AVEO Pharmaceuticals, Inc. (U.S.), Chiasma, Inc. (U.S.), Aegis Therapeutics, LLC (U.S.), CRINETICS PHARMACEUTICALS (U.S.), Delcath Systems Inc. (U.S.), Exelixis, Inc. (U.S.), and others.

Segments for Global Carcinoid Tumor Market

The global carcinoid tumor market is segmented on the basis of site, diagnosis, treatment, and end users.

On the basis of the site, the market is segmented into gastrointestinal, lung, and others. Furthermore, the gastrointestinal segment is sub-segmented into rectum, small intestine, appendix, and others. Lung segment is sub-segmented into typical, atypical, and others.

On the basis of the diagnosis, the market is segmented into serology, imaging, biopsy, and others. The serology segment is sub-segmented into blood test, urine test, molecular test, and others. The imaging segment is sub-segmented into X-ray, CT scan, PET scan, and others.

On the basis of the treatment, the market is segmented into surgery, chemotherapy, radiotherapy, and others. The surgery segment is sub-segmented into local excision, radiofrequency ablation (RFA), and others.

On the basis of the end users, the market is segmented into hospitals & clinics, academic institutes, research organization, and others.

Regional Analysis for Global Carcinoid Tumor Market

America dominates the global carcinoid tumor market owing to a well-developed healthcare sector and huge patient population. Apart from this, increasing healthcare expenditure and presence of developed economies like the U.S. and Canada within the region have boosted the growth of the market in America.

Europe is the second leading market across the globe, which is followed by Asia Pacific owing to availability of funds for research, huge patient population, and strong government support for research & development. According to the National Health Service in 2015, each year about 1,200 people are diagnosed with carcinoid tumor in the UK.

Asia Pacific is the fastest growing region in the market due to the presence of a huge patient population and continuously developing economies like India and China, which have rising healthcare expenditure. Moreover, favorable governmental policies and the presence of huge opportunity in the untapped market within the region are likely to fuels the market growth during the forecast period.

On the other hand, the Middle East & Africa holds the least share in the global carcinoid tumor market due to presence of poor economy, especially, in Africa region. Majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure. The presence of developed economies like Qatar, Saudi Arabia, Dubai, and others within the region fuels the market growth.

To Browse Complete Report visit https://www.marketresearchfuture.com/reports/carcinoid-tumor-market-4813

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Carcinoid Tumor Market To Reach Around 10.0% CAGR till 2023 by Top Players as Novartis AG, Amgen, Boehringer Ingelheim GmbH, AVEO Pharmaceuticals, Chiasma, Aegis Therapeutics, etc here

News-ID: 1372186 • Views:

More Releases from Market Research Future

Generative AI in Fintech Market to Grow at a CAGR of 24.5% by 2032
Generative AI in Fintech Market to Grow at a CAGR of 24.5% by 2032
Generative AI in Fintech Market Overview: Generative AI has been making significant strides in the FinTech market, offering a wide range of applications and opportunities for growth. Market Size and Growth: The generative AI in fintech Market is projected to grow from USD 1,111.0 million in 2023 to USD 7,984.6 million by 2032, exhibiting a compound annual growth rate (CAGR) of 24.5% during the forecast period (2023 - 2032). Indicating exponential growth and
Pharmaceutical Packaging Market Size, Share Growth Status, Emerging Technology, Key Players, Industry Challenges, and Forecast till 2032
Pharmaceutical Packaging Market Size, Share Growth Status, Emerging Technology, …
In the ever-evolving landscape of the pharmaceutical industry, packaging plays a pivotal role in ensuring the safety, efficacy, and integrity of medical products. The pharmaceutical packaging market is witnessing dynamic growth driven by technological advancements, stringent regulatory requirements, and increasing demand for personalized medicine and biologics. With a focus on patient safety, convenience, and sustainability, the market is undergoing transformative changes, fostering innovation and creativity among industry players. Pharmaceutical Packaging Market
US Color Cosmetics Market Report Presents an Overall Analysis, Development Trends, Driving Forces, Opportunities
US Color Cosmetics Market Report Presents an Overall Analysis, Development Trend …
Color cosmetics have long been an integral part of American culture, offering a wide range of products to enhance beauty and express individuality. The US color cosmetics market is a dynamic and vibrant landscape, driven by evolving consumer preferences, innovative product offerings, and changing beauty trends. In this article, we explore the key drivers, trends, restraints, and opportunities shaping the US color cosmetics market. The US Color Cosmetics Market was valued
US Takeout Containers Market Key Players, End User Demand and Analysis Growth Trends by 2032
US Takeout Containers Market Key Players, End User Demand and Analysis Growth Tr …
Takeout containers have become an integral part of the modern dining experience, offering convenience and portability for consumers on-the-go. In the United States, the takeout containers market has witnessed significant growth in recent years, driven by changing consumer lifestyles, the rise of food delivery services, and increasing environmental concerns. This article explores the key trends, drivers, restraints, and opportunities shaping the US takeout containers market. US Takeout Containers Market size was

All 5 Releases


More Releases for Carcinoid

Carcinoid Syndrome Diarrhea Treatment Market - Increasing prevalence of rare car …
Carcinoid Syndrome Diarrhea Treatment Market report is a exploration database spread across colorful runners with multiple tables and numbers in it. The exploration covers a precious source of perceptive information for business strategists. Carcinoid Syndrome Diarrhea Treatment Industry provides the overview with growth analysis and literal & futuristic cost, profit, demand and force data (as applicable). The exploration judges give an elegant description of the value chain and its distributor
Carcinoid Syndrome Diarrhea Treatment Market Size, Status and Forecast To
Carcinoid Syndrome Diarrhea Treatment Market The Global Carcinoid Syndrome Diarrhea Treatment Market research report provides a unique methodology for evaluating the market insights, highlighting opportunities and supporting strategic and tactical decision-making. This report recognizes the requirement of a rapidly-evolving and competitive environment, up-to-date marketing information is essential to monitor performance and make critical decisions for growth and profitability. It provides information on the latest trends and developments and focuses on innovations
Carcinoid Syndrome Management Market to Witness Exponential Growth by 2027
Carcinoid syndrome comprises of signs and symptoms such as flushing of the face, debilitating diarrhea, asthma caused due to vasoconstriction, intestinal bleeding, fast heartbeat, shortness of breath, sweating, unexplained weight gain etc. which are developed secondary to carcinoid tumor. The term ‘carcinoid crisis’ is used when all the symptoms of carcinoid syndrome show at a time. Carcinoid tumors arise out of neuroendocrine cells which are present all over the human
Carcinoid Syndrome Diarrhea Treatment Market
Increasing prevalence of rare carcinoid syndrome diarrhea to boost market growth According to the National Organization for Rare Disorders (NORD), 2017, each year, only 27 individuals per million population are estimated to be diagnosed with carcinoid tumors in the U.S., amongst whom, only 10% individuals develop carcinoid syndrome. Moreover, it affects both males and females in equal number. Increasing prevalence of the disease is in turn, increasing demand for carcinoid syndrome
Carcinoid Syndrome Management Market Challenges and Opportunities Report 2017-20 …
Carcinoid syndrome comprises of signs and symptoms such as flushing of the face, debilitating diarrhea, asthma caused due to vasoconstriction, intestinal bleeding, fast heartbeat, shortness of breath, sweating, unexplained weight gain etc. which are developed secondary to carcinoid tumor. The term ‘carcinoid crisis’ is used when all the symptoms of carcinoid syndrome show at a time. Carcinoid tumors arise out of neuroendocrine cells which are present all over the human
Carcinoid Syndrome Diarrhea Treatment Market
Carcinoid syndrome is caused by secretion of certain harmful chemicals by carcinoid tumors. Carcinoid syndrome may occur due to infection or other related diseases, and medical or surgical treatments such as anesthesia, chemotherapy, embolization, and tumor debulking. The key symptoms of the syndrome include flushing of the skin and diarrhea, rapid heartbeat, and bronchoconstriction. If remained undiagnosed, it could lead to several complications such as weight loss, electrolyte imbalance, dehydrations,